Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Venus MedTech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$5.6

2024-10-29

Market Capitalization

$2.5 B

2024-10-29

Revenue

¥306.8 M

FY, 2025

CreditSafe Score

?
Score changed on Jul 01, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue115.3M233.3M276.0M415.9M406.5M491.4M470.8M306.8M
Cost of goods sold16.4M38.6M48.8M91.5M92.5M102.2M103.1M95.0M
Gross profit101.1M203.9M257.3M332.9M345.6M412.2M391.4M239.5M
Gross profit margin, %87.6%87.4%93.2%80.1%85.0%83.9%83.1%78.1%
Operating expense total396.5M527.5M429.3M940.6M1.0B918.4M993.6M528.0M
Depreciation and amortization10.0M28.9M37.7M51.6M532.6M373.6M111.1M97.3M
EBITDA(295.5M)(323.6M)(171.5M)(619.4M)(673.4M)(518.6M)(606.4M)(290.6M)
EBITDA margin, %-256.2%-138.7%-62.1%-148.9%-165.7%-105.5%-128.8%-94.7%
EBIT(305.8M)(352.5M)(201.7M)(432.0M)(1.2B)(732.8M)(713.9M)(393.6M)
EBIT margin, %-265.1%-151.1%-73.1%-103.9%-296.7%-149.1%-151.6%-128.3%
Interest income881.0K6.2M34.7M49.5M34.6M34.5M10.4M5.0M
Interest expense3.2M21.9M4.2M1.9M44.6M62.7M16.6M18.0M
Pre tax profit(299.6M)(381.5M)(185.8M)(377.6M)(1.2B)(735.3M)(740.7M)(404.9M)
Income tax expense898.0K(778.0K)(3.0M)(6.2M)(34.3M)(6.3M)(23.3M)2.8M
Net Income(300.5M)(380.8M)(182.9M)(371.4M)(1.1B)(729.1M)(717.4M)(407.7M)

Footer menu